フェニルケトン尿症治療の世界市場 (2024～2028年)

フェニルケトン尿症治療市場 (2024～2028年)

フェニルケトン尿症治療市場は2023-2028年に3億3,960万米ドル分拡大し、予測期間中に6.7%のCAGRで成長すると予測されます。当レポートでは、フェニルケトン尿症治療市場の全体的な分析、市場規模・予測、動向、成長促進要因、課題、約25のベンダーを網羅したベンダー分析などを掲載しています。

当レポートでは、現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。市場は、ゲノム研究開発への投資の増加、PKUの有病率の増加、パイプライン医薬品の存在によって牽引されています。

当レポートでは、今後数年間のフェニルケトン尿症治療市場の成長を促進する主な要因の1つとして、ベンダーによる戦略的提携の高まりを挙げています。また、新薬の開発と商業化の進展や、医療産業の進歩により、同市場には大きな需要が見込まれます。

目次

第1章 エグゼクティブサマリー

• 市場概要

第2章 Technavioによる分析

• 価格感応度・ライフサイクル・顧客購入バスケット・採用率・購入基準の分析
• インプットの重要性と差別化の要因
• 混乱の要因
• 促進要因と課題の影響

第3章 市場情勢

• 市場エコシステム
• 市場の特徴
• バリューチェーン分析

第4章 市場規模

• 市場の定義
• 市場セグメント分析
• 市場規模 (2023年)
• 市場の見通し (2023～2028年)

第5章 市場規模実績

• フェニルケトン尿症治療の世界市場 (2018～2022年)
• 薬剤クラス別分析 (2018～2022年)
• 地域別分析 (2018～2022年)
• 国別分析 (2018～2022年)

第6章 ファイブフォース分析

• ファイブフォースの要約
• 買い手の交渉力
• 供給企業の交渉力
• 新規参入業者の脅威
• 代替品の脅威
• 競争の脅威
• 市況

第7章 市場セグメンテーション：薬剤クラス別

• 市場セグメント
• 比較：薬剤クラス別
• サプロプテリン：市場規模と予測 (2023～2028年)
• ペグバリアーゼ-pqpz：市場規模と予測 (2023～2028年)
• 市場機会：薬剤クラス別

第8章 顧客情勢

• 顧客情勢の概要

第9章 地域別情勢

• 地域別セグメンテーション
• 地域別比較
• 北米：市場規模と予測 (2023～2028年)
• 欧州：市場規模と予測 (2023～2028年)
• アジア：市場規模と予測 (2023～2028年)
• 世界のその他の地域：市場規模と予測 (2023～2028年)
• 米国：市場規模と予測 (2023～2028年)
• カナダ：市場規模と予測 (2023～2028年)
• オーストラリア：市場規模と予測 (2023～2028年)
• アイルランド：市場規模と予測 (2023～2028年)
• メキシコ：市場規模と予測 (2023～2028年)
• フィンランド：市場規模と予測 (2023～2028年)
• 中国：市場規模と予測 (2023～2028年)
• ロシア：市場規模と予測 (2023～2028年)
• インド：市場規模と予測 (2023～2028年)
• デンマーク：市場規模と予測 (2023～2028年)
• 市場機会：地域別

第10章 促進要因・課題・機会・抑制要因

• 市場促進要因
• 市場の課題
• 促進要因と課題の影響
• 市場の機会・抑制要因

第11章 競合情勢

• 概要
• 競合情勢
• 混乱の状況
• 業界のリスク

第12章 競合分析

• 企業プロファイル
• 企業ランキング指数
• 企業の市場ポジショニング
• American Gene Technologies
• BioMarin Pharmaceutical Inc.
• Codexis Inc
• Dr. Schar
• Evox Therapeutics Ltd.
• Homology Medicines Inc.
• Jnana Therapeutics
• Nestle Health Science S.A.
• SOM Innovation Biotech S.A.
• Synlogic Inc.

第13章 付録

Exhibits:

• Exhibits1: Executive Summary - Chart on Market Overview
• Exhibits2: Executive Summary - Data Table on Market Overview
• Exhibits3: Executive Summary - Chart on Global Market Characteristics
• Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
• Exhibits5: Executive Summary - Chart on Market Segmentation by Drug Class
• Exhibits6: Executive Summary - Chart on Incremental Growth
• Exhibits7: Executive Summary - Data Table on Incremental Growth
• Exhibits8: Executive Summary - Chart on Company Market Positioning
• Exhibits9: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits10: Overview on criticality of inputs and factors of differentiation
• Exhibits11: Overview on factors of disruption
• Exhibits12: Impact of drivers and challenges in 2023 and 2028
• Exhibits13: Parent Market
• Exhibits14: Data Table on - Parent Market
• Exhibits15: Market characteristics analysis
• Exhibits16: Value Chain Analysis
• Exhibits17: Offerings of companies included in the market definition
• Exhibits18: Market segments
• Exhibits19: Chart on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits20: Data Table on Global - Market size and forecast 2023-2028 ($ million)
• Exhibits21: Chart on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits22: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
• Exhibits23: Historic Market Size - Data Table on Global Phenylketonuria Treatment Market 2018 - 2022 ($ million)
• Exhibits24: Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
• Exhibits25: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• Exhibits26: Historic Market Size - Country Segment 2018 - 2022 ($ million)
• Exhibits27: Five forces analysis - Comparison between 2023 and 2028
• Exhibits28: Bargaining power of buyers - Impact of key factors 2023 and 2028
• Exhibits29: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• Exhibits30: Threat of new entrants - Impact of key factors in 2023 and 2028
• Exhibits31: Threat of substitutes - Impact of key factors in 2023 and 2028
• Exhibits32: Threat of rivalry - Impact of key factors in 2023 and 2028
• Exhibits33: Chart on Market condition - Five forces 2023 and 2028
• Exhibits34: Chart on Drug Class - Market share 2023-2028 (%)
• Exhibits35: Data Table on Drug Class - Market share 2023-2028 (%)
• Exhibits36: Chart on Comparison by Drug Class
• Exhibits37: Data Table on Comparison by Drug Class
• Exhibits38: Chart on Sapropterin - Market size and forecast 2023-2028 ($ million)
• Exhibits39: Data Table on Sapropterin - Market size and forecast 2023-2028 ($ million)
• Exhibits40: Chart on Sapropterin - Year-over-year growth 2023-2028 (%)
• Exhibits41: Data Table on Sapropterin - Year-over-year growth 2023-2028 (%)
• Exhibits42: Chart on Pegvaliase-pqpz - Market size and forecast 2023-2028 ($ million)
• Exhibits43: Data Table on Pegvaliase-pqpz - Market size and forecast 2023-2028 ($ million)
• Exhibits44: Chart on Pegvaliase-pqpz - Year-over-year growth 2023-2028 (%)
• Exhibits45: Data Table on Pegvaliase-pqpz - Year-over-year growth 2023-2028 (%)
• Exhibits46: Market opportunity by Drug Class ($ million)
• Exhibits47: Data Table on Market opportunity by Drug Class ($ million)
• Exhibits48: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• Exhibits49: Chart on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits50: Data Table on Market share By Geographical Landscape 2023-2028 (%)
• Exhibits51: Chart on Geographic comparison
• Exhibits52: Data Table on Geographic comparison
• Exhibits53: Chart on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits54: Data Table on North America - Market size and forecast 2023-2028 ($ million)
• Exhibits55: Chart on North America - Year-over-year growth 2023-2028 (%)
• Exhibits56: Data Table on North America - Year-over-year growth 2023-2028 (%)
• Exhibits57: Chart on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits58: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
• Exhibits59: Chart on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits60: Data Table on Europe - Year-over-year growth 2023-2028 (%)
• Exhibits61: Chart on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits62: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
• Exhibits63: Chart on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits64: Data Table on Asia - Year-over-year growth 2023-2028 (%)
• Exhibits65: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits66: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
• Exhibits67: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits68: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• Exhibits69: Chart on US - Market size and forecast 2023-2028 ($ million)
• Exhibits70: Data Table on US - Market size and forecast 2023-2028 ($ million)
• Exhibits71: Chart on US - Year-over-year growth 2023-2028 (%)
• Exhibits72: Data Table on US - Year-over-year growth 2023-2028 (%)
• Exhibits73: Chart on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits74: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
• Exhibits75: Chart on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits76: Data Table on Canada - Year-over-year growth 2023-2028 (%)
• Exhibits77: Chart on Australia - Market size and forecast 2023-2028 ($ million)
• Exhibits78: Data Table on Australia - Market size and forecast 2023-2028 ($ million)
• Exhibits79: Chart on Australia - Year-over-year growth 2023-2028 (%)
• Exhibits80: Data Table on Australia - Year-over-year growth 2023-2028 (%)
• Exhibits81: Chart on Ireland - Market size and forecast 2023-2028 ($ million)
• Exhibits82: Data Table on Ireland - Market size and forecast 2023-2028 ($ million)
• Exhibits83: Chart on Ireland - Year-over-year growth 2023-2028 (%)
• Exhibits84: Data Table on Ireland - Year-over-year growth 2023-2028 (%)
• Exhibits85: Chart on Mexico - Market size and forecast 2023-2028 ($ million)
• Exhibits86: Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
• Exhibits87: Chart on Mexico - Year-over-year growth 2023-2028 (%)
• Exhibits88: Data Table on Mexico - Year-over-year growth 2023-2028 (%)
• Exhibits89: Chart on Finland - Market size and forecast 2023-2028 ($ million)
• Exhibits90: Data Table on Finland - Market size and forecast 2023-2028 ($ million)
• Exhibits91: Chart on Finland - Year-over-year growth 2023-2028 (%)
• Exhibits92: Data Table on Finland - Year-over-year growth 2023-2028 (%)
• Exhibits93: Chart on China - Market size and forecast 2023-2028 ($ million)
• Exhibits94: Data Table on China - Market size and forecast 2023-2028 ($ million)
• Exhibits95: Chart on China - Year-over-year growth 2023-2028 (%)
• Exhibits96: Data Table on China - Year-over-year growth 2023-2028 (%)
• Exhibits97: Chart on Russia - Market size and forecast 2023-2028 ($ million)
• Exhibits98: Data Table on Russia - Market size and forecast 2023-2028 ($ million)
• Exhibits99: Chart on Russia - Year-over-year growth 2023-2028 (%)
• Exhibits100: Data Table on Russia - Year-over-year growth 2023-2028 (%)
• Exhibits101: Chart on India - Market size and forecast 2023-2028 ($ million)
• Exhibits102: Data Table on India - Market size and forecast 2023-2028 ($ million)
• Exhibits103: Chart on India - Year-over-year growth 2023-2028 (%)
• Exhibits104: Data Table on India - Year-over-year growth 2023-2028 (%)
• Exhibits105: Chart on Denmark - Market size and forecast 2023-2028 ($ million)
• Exhibits106: Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
• Exhibits107: Chart on Denmark - Year-over-year growth 2023-2028 (%)
• Exhibits108: Data Table on Denmark - Year-over-year growth 2023-2028 (%)
• Exhibits109: Market opportunity By Geographical Landscape ($ million)
• Exhibits110: Data Tables on Market opportunity By Geographical Landscape ($ million)
• Exhibits111: Impact of drivers and challenges in 2023 and 2028
• Exhibits112: Overview on criticality of inputs and factors of differentiation
• Exhibits113: Overview on factors of disruption
• Exhibits114: Impact of key risks on business
• Exhibits115: Companies covered
• Exhibits116: Company ranking index
• Exhibits117: Matrix on companies position and classification
• Exhibits118: American Gene Technologies - Overview
• Exhibits119: American Gene Technologies - Product / Service
• Exhibits120: American Gene Technologies - Key offerings
• Exhibits121: SWOT
• Exhibits122: BioMarin Pharmaceutical Inc. - Overview
• Exhibits123: BioMarin Pharmaceutical Inc. - Product / Service
• Exhibits124: BioMarin Pharmaceutical Inc. - Key offerings
• Exhibits125: SWOT
• Exhibits126: Codexis Inc - Overview
• Exhibits127: Codexis Inc - Business segments
• Exhibits128: Codexis Inc - Key offerings
• Exhibits129: Codexis Inc - Segment focus
• Exhibits130: SWOT
• Exhibits131: Dr. Schar - Overview
• Exhibits132: Dr. Schar - Product / Service
• Exhibits133: Dr. Schar - Key offerings
• Exhibits134: SWOT
• Exhibits135: Evox Therapeutics Ltd. - Overview
• Exhibits136: Evox Therapeutics Ltd. - Product / Service
• Exhibits137: Evox Therapeutics Ltd. - Key offerings
• Exhibits138: SWOT
• Exhibits139: Homology Medicines Inc. - Overview
• Exhibits140: Homology Medicines Inc. - Product / Service
• Exhibits141: Homology Medicines Inc. - Key offerings
• Exhibits142: SWOT
• Exhibits143: Jnana Therapeutics - Overview
• Exhibits144: Jnana Therapeutics - Product / Service
• Exhibits145: Jnana Therapeutics - Key offerings
• Exhibits146: SWOT
• Exhibits147: Nestle Health Science S.A. - Overview
• Exhibits148: Nestle Health Science S.A. - Product / Service
• Exhibits149: Nestle Health Science S.A. - Key offerings
• Exhibits150: SWOT
• Exhibits151: SOM Innovation Biotech S.A. - Overview
• Exhibits152: SOM Innovation Biotech S.A. - Product / Service
• Exhibits153: SOM Innovation Biotech S.A. - Key offerings
• Exhibits154: SWOT
• Exhibits155: Synlogic Inc. - Overview
• Exhibits156: Synlogic Inc. - Product / Service
• Exhibits157: Synlogic Inc. - Key offerings
• Exhibits158: SWOT
• Exhibits159: Inclusions checklist
• Exhibits160: Exclusions checklist
• Exhibits161: Currency conversion rates for US$
• Exhibits162: Research methodology
• Exhibits163: Information sources
• Exhibits164: Data validation
• Exhibits165: Validation techniques employed for market sizing
• Exhibits166: Data synthesis
• Exhibits167: 360 degree market analysis
• Exhibits168: List of abbreviations

Phenylketonuria Treatment Market 2024-2028

The phenylketonuria treatment market is forecasted to grow by USD 339.6 mn during 2023-2028, accelerating at a CAGR of 6.7% during the forecast period. The report on the phenylketonuria treatment market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising investments in genomic research and development, increasing prevalence of pku, and presence of pipeline drugs.

Technavio's phenylketonuria treatment market is segmented as below:

By Drug Class

• Sapropterin
• Pegvaliase-pqpz

By Geographical Landscape

• North America
• Europe
• Asia
• Rest of World (ROW)

This study identifies the rising strategic alliances by vendors as one of the prime reasons driving the phenylketonuria treatment market growth during the next few years. Also, increasing development and commercialization of new drugs and advancements in health care industry will lead to sizable demand in the market.

The report on the phenylketonuria treatment market covers the following areas:

• Phenylketonuria Treatment Market sizing
• Phenylketonuria Treatment Market forecast
• Phenylketonuria Treatment Market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading phenylketonuria treatment market vendors that include American Gene Technologies, BioMarin Pharmaceutical Inc., Codexis Inc, Dr. Schar, Evox Therapeutics Ltd., Homology Medicines Inc., Jnana Therapeutics, Nestle Health Science S.A., SOM Innovation Biotech S.A., and Synlogic Inc.. Also, the phenylketonuria treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.

Table of Contents

1 Executive Summary

• 1.1 Market overview
  • Executive Summary - Chart on Market Overview
  • Executive Summary - Data Table on Market Overview
  • Executive Summary - Chart on Global Market Characteristics
  • Executive Summary - Chart on Market By Geographical Landscape
  • Executive Summary - Chart on Market Segmentation by Drug Class
  • Executive Summary - Chart on Incremental Growth
  • Executive Summary - Data Table on Incremental Growth
  • Executive Summary - Chart on Company Market Positioning

2 Technavio Analysis

• 2.1 Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 2.2 Criticality of inputs and Factors of differentiation
  • Overview on criticality of inputs and factors of differentiation
• 2.3 Factors of disruption
  • Overview on factors of disruption
• 2.4 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028

3 Market Landscape

• 3.1 Market ecosystem
  • Parent Market
  • Data Table on - Parent Market
• 3.2 Market characteristics
  • Market characteristics analysis
• 3.3 Value chain analysis
  • Value Chain Analysis

4 Market Sizing

• 4.1 Market definition
  • Offerings of companies included in the market definition
• 4.2 Market segment analysis
  • Market segments
• 4.3 Market size 2023
• 4.4 Market outlook: Forecast for 2023-2028
  • Chart on Global - Market size and forecast 2023-2028 ($ million)
  • Data Table on Global - Market size and forecast 2023-2028 ($ million)
  • Chart on Global Market: Year-over-year growth 2023-2028 (%)
  • Data Table on Global Market: Year-over-year growth 2023-2028 (%)

5 Historic Market Size

• 5.1 Global Phenylketonuria Treatment Market 2018 - 2022
  • Historic Market Size - Data Table on Global Phenylketonuria Treatment Market 2018 - 2022 ($ million)
• 5.2 Drug Class segment analysis 2018 - 2022
  • Historic Market Size - Drug Class Segment 2018 - 2022 ($ million)
• 5.3 Geography segment analysis 2018 - 2022
  • Historic Market Size - Geography Segment 2018 - 2022 ($ million)
• 5.4 Country segment analysis 2018 - 2022
  • Historic Market Size - Country Segment 2018 - 2022 ($ million)

6 Five Forces Analysis

• 6.1 Five forces summary
  • Five forces analysis - Comparison between 2023 and 2028
• 6.2 Bargaining power of buyers
  • Bargaining power of buyers - Impact of key factors 2023 and 2028
• 6.3 Bargaining power of suppliers
  • Bargaining power of suppliers - Impact of key factors in 2023 and 2028
• 6.4 Threat of new entrants
  • Threat of new entrants - Impact of key factors in 2023 and 2028
• 6.5 Threat of substitutes
  • Threat of substitutes - Impact of key factors in 2023 and 2028
• 6.6 Threat of rivalry
  • Threat of rivalry - Impact of key factors in 2023 and 2028
• 6.7 Market condition
  • Chart on Market condition - Five forces 2023 and 2028

7 Market Segmentation by Drug Class

• 7.1 Market segments
  • Chart on Drug Class - Market share 2023-2028 (%)
  • Data Table on Drug Class - Market share 2023-2028 (%)
• 7.2 Comparison by Drug Class
  • Chart on Comparison by Drug Class
  • Data Table on Comparison by Drug Class
• 7.3 Sapropterin - Market size and forecast 2023-2028
  • Chart on Sapropterin - Market size and forecast 2023-2028 ($ million)
  • Data Table on Sapropterin - Market size and forecast 2023-2028 ($ million)
  • Chart on Sapropterin - Year-over-year growth 2023-2028 (%)
  • Data Table on Sapropterin - Year-over-year growth 2023-2028 (%)
• 7.4 Pegvaliase-pqpz - Market size and forecast 2023-2028
  • Chart on Pegvaliase-pqpz - Market size and forecast 2023-2028 ($ million)
  • Data Table on Pegvaliase-pqpz - Market size and forecast 2023-2028 ($ million)
  • Chart on Pegvaliase-pqpz - Year-over-year growth 2023-2028 (%)
  • Data Table on Pegvaliase-pqpz - Year-over-year growth 2023-2028 (%)
• 7.5 Market opportunity by Drug Class
  • Market opportunity by Drug Class ($ million)
  • Data Table on Market opportunity by Drug Class ($ million)

8 Customer Landscape

• 8.1 Customer landscape overview
  • Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

• 9.1 Geographic segmentation
  • Chart on Market share By Geographical Landscape 2023-2028 (%)
  • Data Table on Market share By Geographical Landscape 2023-2028 (%)
• 9.2 Geographic comparison
  • Chart on Geographic comparison
  • Data Table on Geographic comparison
• 9.3 North America - Market size and forecast 2023-2028
  • Chart on North America - Market size and forecast 2023-2028 ($ million)
  • Data Table on North America - Market size and forecast 2023-2028 ($ million)
  • Chart on North America - Year-over-year growth 2023-2028 (%)
  • Data Table on North America - Year-over-year growth 2023-2028 (%)
• 9.4 Europe - Market size and forecast 2023-2028
  • Chart on Europe - Market size and forecast 2023-2028 ($ million)
  • Data Table on Europe - Market size and forecast 2023-2028 ($ million)
  • Chart on Europe - Year-over-year growth 2023-2028 (%)
  • Data Table on Europe - Year-over-year growth 2023-2028 (%)
• 9.5 Asia - Market size and forecast 2023-2028
  • Chart on Asia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Asia - Market size and forecast 2023-2028 ($ million)
  • Chart on Asia - Year-over-year growth 2023-2028 (%)
  • Data Table on Asia - Year-over-year growth 2023-2028 (%)
• 9.6 Rest of World (ROW) - Market size and forecast 2023-2028
  • Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
  • Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
  • Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
• 9.7 US - Market size and forecast 2023-2028
  • Chart on US - Market size and forecast 2023-2028 ($ million)
  • Data Table on US - Market size and forecast 2023-2028 ($ million)
  • Chart on US - Year-over-year growth 2023-2028 (%)
  • Data Table on US - Year-over-year growth 2023-2028 (%)
• 9.8 Canada - Market size and forecast 2023-2028
  • Chart on Canada - Market size and forecast 2023-2028 ($ million)
  • Data Table on Canada - Market size and forecast 2023-2028 ($ million)
  • Chart on Canada - Year-over-year growth 2023-2028 (%)
  • Data Table on Canada - Year-over-year growth 2023-2028 (%)
• 9.9 Australia - Market size and forecast 2023-2028
  • Chart on Australia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Australia - Market size and forecast 2023-2028 ($ million)
  • Chart on Australia - Year-over-year growth 2023-2028 (%)
  • Data Table on Australia - Year-over-year growth 2023-2028 (%)
• 9.10 Ireland - Market size and forecast 2023-2028
  • Chart on Ireland - Market size and forecast 2023-2028 ($ million)
  • Data Table on Ireland - Market size and forecast 2023-2028 ($ million)
  • Chart on Ireland - Year-over-year growth 2023-2028 (%)
  • Data Table on Ireland - Year-over-year growth 2023-2028 (%)
• 9.11 Mexico - Market size and forecast 2023-2028
  • Chart on Mexico - Market size and forecast 2023-2028 ($ million)
  • Data Table on Mexico - Market size and forecast 2023-2028 ($ million)
  • Chart on Mexico - Year-over-year growth 2023-2028 (%)
  • Data Table on Mexico - Year-over-year growth 2023-2028 (%)
• 9.12 Finland - Market size and forecast 2023-2028
  • Chart on Finland - Market size and forecast 2023-2028 ($ million)
  • Data Table on Finland - Market size and forecast 2023-2028 ($ million)
  • Chart on Finland - Year-over-year growth 2023-2028 (%)
  • Data Table on Finland - Year-over-year growth 2023-2028 (%)
• 9.13 China - Market size and forecast 2023-2028
  • Chart on China - Market size and forecast 2023-2028 ($ million)
  • Data Table on China - Market size and forecast 2023-2028 ($ million)
  • Chart on China - Year-over-year growth 2023-2028 (%)
  • Data Table on China - Year-over-year growth 2023-2028 (%)
• 9.14 Russia - Market size and forecast 2023-2028
  • Chart on Russia - Market size and forecast 2023-2028 ($ million)
  • Data Table on Russia - Market size and forecast 2023-2028 ($ million)
  • Chart on Russia - Year-over-year growth 2023-2028 (%)
  • Data Table on Russia - Year-over-year growth 2023-2028 (%)
• 9.15 India - Market size and forecast 2023-2028
  • Chart on India - Market size and forecast 2023-2028 ($ million)
  • Data Table on India - Market size and forecast 2023-2028 ($ million)
  • Chart on India - Year-over-year growth 2023-2028 (%)
  • Data Table on India - Year-over-year growth 2023-2028 (%)
• 9.16 Denmark - Market size and forecast 2023-2028
  • Chart on Denmark - Market size and forecast 2023-2028 ($ million)
  • Data Table on Denmark - Market size and forecast 2023-2028 ($ million)
  • Chart on Denmark - Year-over-year growth 2023-2028 (%)
  • Data Table on Denmark - Year-over-year growth 2023-2028 (%)
• 9.17 Market opportunity By Geographical Landscape
  • Market opportunity By Geographical Landscape ($ million)
  • Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Opportunity/Restraints

• 10.1 Market drivers
• 10.2 Market challenges
• 10.3 Impact of drivers and challenges
  • Impact of drivers and challenges in 2023 and 2028
• 10.4 Market opportunities/restraints

11 Competitive Landscape

• 11.1 Overview
• 11.2 Competitive Landscape
  • Overview on criticality of inputs and factors of differentiation
• 11.3 Landscape disruption
  • Overview on factors of disruption
• 11.4 Industry risks
  • Impact of key risks on business

12 Competitive Analysis

• 12.1 Companies profiled
  • Companies covered
• 12.2 Company ranking index
  • Company ranking index
• 12.3 Market positioning of companies
  • Matrix on companies position and classification
• 12.4 American Gene Technologies
  • American Gene Technologies - Overview
  • American Gene Technologies - Product / Service
  • American Gene Technologies - Key offerings
  • SWOT
• 12.5 BioMarin Pharmaceutical Inc.
  • BioMarin Pharmaceutical Inc. - Overview
  • BioMarin Pharmaceutical Inc. - Product / Service
  • BioMarin Pharmaceutical Inc. - Key offerings
  • SWOT
• 12.6 Codexis Inc
  • Codexis Inc - Overview
  • Codexis Inc - Business segments
  • Codexis Inc - Key offerings
  • Codexis Inc - Segment focus
  • SWOT
• 12.7 Dr. Schar
  • Dr. Schar - Overview
  • Dr. Schar - Product / Service
  • Dr. Schar - Key offerings
  • SWOT
• 12.8 Evox Therapeutics Ltd.
  • Evox Therapeutics Ltd. - Overview
  • Evox Therapeutics Ltd. - Product / Service
  • Evox Therapeutics Ltd. - Key offerings
  • SWOT
• 12.9 Homology Medicines Inc.
  • Homology Medicines Inc. - Overview
  • Homology Medicines Inc. - Product / Service
  • Homology Medicines Inc. - Key offerings
  • SWOT
• 12.10 Jnana Therapeutics
  • Jnana Therapeutics - Overview
  • Jnana Therapeutics - Product / Service
  • Jnana Therapeutics - Key offerings
  • SWOT
• 12.11 Nestle Health Science S.A.
  • Nestle Health Science S.A. - Overview
  • Nestle Health Science S.A. - Product / Service
  • Nestle Health Science S.A. - Key offerings
  • SWOT
• 12.12 SOM Innovation Biotech S.A.
  • SOM Innovation Biotech S.A. - Overview
  • SOM Innovation Biotech S.A. - Product / Service
  • SOM Innovation Biotech S.A. - Key offerings
  • SWOT
• 12.13 Synlogic Inc.
  • Synlogic Inc. - Overview
  • Synlogic Inc. - Product / Service
  • Synlogic Inc. - Key offerings
  • SWOT

13 Appendix

• 13.1 Scope of the report
• 13.2 Inclusions and exclusions checklist
  • Inclusions checklist
  • Exclusions checklist
• 13.3 Currency conversion rates for US$
  • Currency conversion rates for US$
• 13.4 Research methodology
  • Research methodology
• 13.5 Data procurement
  • Information sources
• 13.6 Data validation
  • Data validation
• 13.7 Validation techniques employed for market sizing
  • Validation techniques employed for market sizing
• 13.8 Data synthesis
  • Data synthesis
• 13.9 360 degree market analysis
  • 360 degree market analysis
• 13.10 List of abbreviations
  • List of abbreviations